| CXSL2200462 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-09-16 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2200463 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-09-16 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2200528 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2200529 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2300108 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-09 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd | | | view |
| CXSL2300110 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-09 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd | | | view |
| CXSL2400135 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-02-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2400136 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-02-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2400635 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-09-21 | | CSPC Megalith Biopharmaceutical Co Ltd | | | view |
| JXSB2300033 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Supplementary Application | 2023-03-28 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JXSL2200010 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Import Drug Application | 2022-01-19 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2300040 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-02-23 | | Janssen-Cilag International NV;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2300072 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.4) | Import Drug Application | 2023-04-21 | | Janssen-Cilag AG;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSS2000019 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-07-02 | view |
| JXSS2000020 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-07-02 | view |
| JXSS2000050 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-06 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | Certificate Issued | 2021-10-11 | view |
| JXSS2100015 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | Certificate Issued | 2021-11-12 | view |
| JXSS2100016 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV | Certificate Issued | 2021-11-12 | view |
| JXSS2200013 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-04-15 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JXSS2500061 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-14 | | Johnson & Johnson;Cilag AG;Janssen-Cilag International NV | | | view |
